Abbvie Limited

Politician(s) lobbied: Naoise Ó Muirí (TD), Dáil Éireann, the Oireachtas

Intent: To brief the Deputy on the potential implications of the UWWTD

Methods: EmailMeeting

Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; John Shaw (Assistant Secretary), Department of the Taoiseach

Intent: To provide AbbVie's perspective on the company's operational experience in Ireland as well as the EU's competitiveness in relation to pharmaceutical innovation.

Methods: Conference Call

Politician(s) lobbied: Dara Calleary (Minister of State), Department of Enterprise, Trade and Employment

Intent: To ensure a satisfactory quality of energy for manufacturers in Ireland.

Methods: EmailPhone callEvent / Reception

Politician(s) lobbied: Muiris O’Connor (Assistant Secretary), Department of Health

Intent: To raise industry wide concerns regarding the impact of some aspects of the EU Commission’s proposals to revise the general pharmaceutical legislation, on IP protection. To discuss the Irish Government's position and its potential impact.

Methods: Meeting

Politician(s) lobbied: Billy Kelleher (MEP), European Parliament

Intent: Awareness of the potential impact of the proposed European Pharmaceutical Strategy.

Methods: Meeting

Politician(s) lobbied: Simon Coveney (Minister), Department of Enterprise, Trade and Employment

Intent: Awareness of the potential impact of the proposed European Pharmaceutical Strategy. Briefed the Minister on the Irish access to medicines environment.

Methods: Meeting

Politician(s) lobbied: Michael McGrath (Minister), Department of Finance; Simon Coveney (Minister), Department of Enterprise, Trade and Employment

Intent: To highlight the importance of a specific allocation in Budget 2024 for the adoption of new medicines in Ireland.

Methods: Letter

Politician(s) lobbied: Neale Richmond (Minister of State), Department of Enterprise, Trade and Employment

Intent: Awareness of the potential impact of the proposed European Pharmaceutical Strategy. Briefed the Minister on the Irish access to medicines environment.

Methods: Meeting

Politician(s) lobbied: Deirdre Clune (MEP), European Parliament

Intent: Awareness of the potential impact of the proposed European Pharmaceutical Strategy.

Methods: Meeting

Politician(s) lobbied: Cathal Crowe (TD), Dáil Éireann, the Oireachtas; Marian Harkin (TD), Dáil Éireann, the Oireachtas

Intent: To improve dermatology waiting lists

Methods: Meeting